Plain-English translation of NCT07202884 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a medication called to see if it can help women who leak urine during everyday activities like coughing, exercising, or sneezing. About 1,000 women will participate across two similar studies. Half will take the new medication, and half will take a placebo (a pill with no active ingredient) so researchers can compare how well the treatment works.
Stress urinary incontinence is a common problem for women, especially those who are overweight or have obesity, and current treatment options are limited. This medication could offer a new way to help reduce accidental urine leakage without surgery.
You likely qualify if…
You likely don't qualify if…
You would take a pill by mouth once every day for several months. You'll have multiple visits to the research clinic where staff will check your health and ask you questions about your symptoms. The entire study lasts about 58 weeks, including an initial screening period and a final safety check-up after the treatment ends. You'll be randomly assigned to receive either the new medication or a placebo, and neither you nor the researchers will know which one you're taking.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
United States